Treatment research progress of primary immune thrombocytopenia
10.3760/cma.j.issn.1008-6706.2019.02.035
- VernacularTitle:原发免疫性血小板减少症治疗进展
- Author:
Dongfeng MAO
1
;
Junfeng MAO
;
Tao WU
;
Hai BAI
Author Information
1. 兰州军区兰州总医院全军血液病中心 730050
- Keywords:
Thrombocytopenia;
Thrombopoietin;
Mesenchymal stem cell tranaplantation;
Splenectomy;
Glucocorticoids;
Gamma-globulins
- From:
Chinese Journal of Primary Medicine and Pharmacy
2019;26(2):253-256
- CountryChina
- Language:Chinese
-
Abstract:
Primary immune thrombocytopenia is an autoimmune disease characterized by reduced platelets, accompanied by or without skin mucous bruises,epistaxis,internal bleeding,etc.Recent years,the treatment of primary immune thrombocytopenia developed very quickly, including the appearance of platelet receptor agonist - Eltrom-bopag.Here,we reviewed the treatment and research development of primary immune thrombocytopenia.
